Skip to main content
KOMIPHARM INTERNATIONAL CO., LTD. logo

KOMIPHARM INTERNATIONAL CO., LTD. — Investor Relations & Filings

Ticker · 041960 ISIN · KR7041960006 KO Manufacturing
Open in API
Filings indexed 326 across all filing types
Latest filing 2019-09-04 Capital/Financing Update
Country KR South Korea
Listing KO 041960

About KOMIPHARM INTERNATIONAL CO., LTD.

https://komipharm.co.kr/en/

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Recent filings

Filing Released Lang Actions
전환가액의조정(제12회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the methodology used for the adjustment based on market price fluctuations. This falls under capital structure changes and financing updates, specifically related to convertible debt instruments.
2019-09-04 Korean
투자판단관련주요경영사항(뇌암 교모세포종 임상2상 임상개시 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean company Komipharm, titled 'Investment Judgment Related Major Management Matters'. It details the approval of a Phase 2 clinical trial for a brain cancer drug (PAX-1-002) in Australia. Since this is a specific regulatory announcement regarding company operations and clinical trial status that does not fit into financial reporting or other specialized categories, it is classified as a general regulatory filing.
2019-08-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Yoo Kyung-ho) of Komipharm. This type of filing, which details personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS) in the provided taxonomy.
2019-08-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the shareholding changes of a specific director/executive (Yang Yong-jin) of Komipharm. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives.
2019-08-20 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company Komipharm, covering the period from January 1, 2019, to June 30, 2019. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). It details the shareholding changes of an executive (Yang Yong-jin) of Komipharm. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS).
2019-08-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.